X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
MERCK LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

MERCK LIMITED  (EMER)


Here is the latest financial fact sheet of Merck Ltd. For more details, see the Merck Ltd quarterly results and Merck Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
merck ltd - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 1,052.7       No. of shares m 16.60
    Mkt Cap Rs m 17,474       % ch % 2.3
    Vol '000 9.7       % ch week % 4.5
    P/E X 24.2       % ch 1-mth % -3.2
    P/CF X 22.7       % ch 12-mth % 63.1
    EPS (TTM) Rs 43.5       52 week H/L Rs 1,155.0/625.0
(As on Mar 23, 2017 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Dec-11
12
Dec-12
12
Dec-13
12
Dec-14
12
Dec-15
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs7607146899191,004 
Low Rs553555523536716 
Sales per share (Unadj.) Rs355.2414.0480.6522.6566.0 
Earnings per share (Unadj.) Rs38.447.233.726.032.3 
Diluted earnings per shareRs38.447.233.726.032.3 
Cash flow per share (Unadj.) Rs43.252.639.733.746.4 
Dividends per share (Unadj.) Rs02.508.506.007.50 
Adj. dividends per shareRs0.002.508.506.007.50 
Dividend yield (eoy) %00.41.40.80.9 
Book value per share (Unadj.) Rs247.0291.4315.1333.9356.4 
Adj. book value per shareRs247.0291.4315.1333.9356.4 
Shares outstanding (eoy) m16.6016.6016.6016.6016.60 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x1.81.51.31.41.5 
Avg P/E ratio x17.113.418.027.926.7 
P/CF ratio (eoy) x15.212.115.221.618.5 
Price / Book Value ratio x2.72.21.92.22.4 
Dividend payout %05.325.323.023.2 
Avg Mkt Cap Rs m10,89810,53310,05612,07514,276 
No. of employees `0001.31.31.51.51.6 
Total wages/salary Rs m8118531,0101,1361,234 
Avg. sales/employee Rs Th4,690.35,382.05,332.85,726.06,045.7 
Avg. wages/employee Rs Th645.2668.0674.9749.6794.0 
Avg. net profit/employee Rs Th506.6613.9373.5285.3344.7 
  INCOME DATA
Net Sales Rs m5,8966,8737,9788,6759,395 
Other income Rs m169202215203233 
Total revenues Rs m6,0657,0758,1928,8789,628 
Gross profit Rs m8671,055769589834 
Depreciation Rs m8089101127234 
Interest Rs m00000 
Profit before tax Rs m9561,168883666833 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m319384324233298 
Profit after tax Rs m637784559432536 
Gross profit margin %14.715.39.66.88.9 
Effective tax rate %33.432.936.735.135.7 
Net profit margin %10.811.47.05.05.7 
  BALANCE SHEET DATA
Current assets Rs m3,7944,5854,7774,9865,724 
Current liabilities Rs m7659711,1201,3521,659 
Net working cap to sales %51.452.645.841.943.3 
Current ratio x5.04.74.33.73.5 
Inventory Days Days7070697565 
Debtors Days Days3834384449 
Net fixed assets Rs m7197699411,3731,387 
Share capital Rs m166166166166166 
"Free" reserves Rs m3,9324,6685,0625,3745,747 
Net worth Rs m4,1014,8375,2305,5435,916 
Long term debt Rs m00000 
Total assets Rs m4,9965,9436,4837,0827,840 
Interest coverage xNMNMNMNMNM 
Debt to equity ratio x00000 
Sales to assets ratio x1.21.21.21.21.2 
Return on assets %12.713.28.66.16.8 
Return on equity %15.516.210.77.89.1 
Return on capital %23.324.116.912.014.1 
Exports to sales %9.110.68.97.88.5 
Imports to sales %24.322.423.722.821.6 
Exports (fob) Rs m539730708677802 
Imports (cif) Rs m1,4311,5401,8881,9812,026 
Fx inflow Rs m572802746824874 
Fx outflow Rs m1,7061,8962,2812,3112,356 
Net fx Rs m-1,135-1,094-1,535-1,487-1,483 
  CASH FLOW
From Operations Rs m 188 543 5 50 837 
From Investments Rs m -91 -818 70 106 -680 
From Financial Activity Rs m 0 0 -48 -166 -119 
Net Cashflow Rs m 97 -276 27 -11 37 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for merck limited

 Share Holding
Indian Promoters : 0.0%
Foreign collaborators : 51.8%
Indian inst/Mut Fund : 18.2%
FIIs : 1.0%
ADR/GDR : 0.0%
Free float : 29.1%
Shareholders : 28,591
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: Shiv Sagar Estate 'A', Dr. Annie Besant Road, Worli, Mumbai - 400 018
    E-MAIL: vikas.r.gupta@merckgroup.com     WEB: www.merck.co.in
    TELEPHONE: (022) 6660 9111     FAX: (022) 2495 0307
    SECTOR: PHARMACEUTICALS     GROUP: M N C
    TR AGENT: Sharepro Serv., 13 AB, Samhita Warehousing, 2nd Flr, Andheri (E), Mumbai-72
    AUDITOR: B. S. R & Co.
CHM: S. N. Talwar COMP SEC: Vikas R. Gupta YEAR OF INC: 1967 BSE CODE: 500126 FV (Rs): 10 DIV YIELD (%): 0.7

More pharmaceuticals Company Fact Sheets:   SUN PHARMARANBAXY LABIPCA LABSUNICHEM LABPIRAMAL ENTERPRISES


Today's Market

Sensex Closes Firm; NTPC Surges 2.3%(Closing)

Indian share markets continued to trade higher owing to firm global cues with energy stocks leading the gains, while financial stocks and auto stocks bounced back.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

Bluechips Have 60% Chance Of Losing Money At Current Levels. But a Small Group Won't...(The 5 Minute Wrapup)

Mar 17, 2017

The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.

As Digital Transactions Fall, Indians Are Going Back to Cash(Vivek Kaul's Diary)

Mar 16, 2017

Digital transactions have fallen since December 2016 both in value and volume terms.

Stock Markets and Gold Rally, Dollar Tumbles(Chart Of The Day)

Mar 16, 2017

Markets are moving up even after the fed interest rate hike.

Why You Should Try SCOREFASTTM Right Now(Daily Profit Hunter)

Mar 10, 2017

Asad Dossani discusses why SCOREFASTM will be a successful trading strategy

4 Things To Watch Out For After Modi's Landslide Win In UP Polls(Outside View)

Mar 15, 2017

PersonalFN explains why you need to wary while investing in equities despite Modi's UP win.

More

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON MERCK LTD

MERCK LTD 8-QTR ANALYSIS

Detailed Quarterly Results With Charts

COMPARE MERCK LTD WITH

MARKET STATS